GeneDx Holdings (WGS) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -142.86% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 11.31% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 9.85% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 17.23% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 60.00% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 15.00% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -20.00% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 6.10% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 6.66% |
| 10 | GeneDx Holdings | 1.60 Bn | 1.43 Bn | 68.21 Mn | -839.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -839.13% |
| Dec 31, 2025 | -365.22% |
| Sep 30, 2025 | 12.90% |
| Jun 30, 2025 | 132.73% |
| Mar 31, 2025 | 70.51% |
| Dec 31, 2024 | 125.00% |
| Sep 30, 2024 | 81.10% |
| Jun 30, 2024 | 40.22% |
| Mar 31, 2024 | 74.34% |
| Dec 31, 2023 | 96.82% |
| Sep 30, 2023 | 75.60% |
| Jun 30, 2023 | 78.04% |
| Mar 31, 2023 | 70.71% |
| Dec 31, 2022 | -3,056.12% |
| Sep 30, 2022 | -4,300.00% |
| Jun 30, 2022 | 80.02% |
| Mar 31, 2022 | 97.02% |
| Dec 31, 2021 | -100.00% |
| Sep 30, 2021 | 100.00% |